Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition

Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis

(2018) Jennifer L McQuade et al.   LANCET ONCOLOGY

Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC)

(2017) Vincent K. Lam et al.   LUNG CANCER

Clinical Features of Acquired Resistance to Anti–PD-1 Therapy in Advanced Melanoma

(2017) Daniel Y. Wang et al.   Cancer Immunology Research

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

(2016) Willy Hugo et al.   CELL

Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests

(2016) Soumya Swaminathan et al.   CLINICAL INFECTIOUS DISEASES

Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review

(2016) Shlomit Strulov Shachar et al.   EUROPEAN JOURNAL OF CANCER

Adapting machine learning techniques to censored time-to-event health record data: A general-purpose approach using inverse probability of censoring weighting

(2016) David M. Vock et al.   JOURNAL OF BIOMEDICAL INFORMATICS

Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial

(2016) F Stephen Hodi et al.   LANCET ONCOLOGY

The Obesity Paradox in Cancer: a Review

(2016) Hannah Lennon et al.   Current Oncology Reports

Low Body Mass Index, Serum Creatinine, and Cause of Death in Patients Undergoing Percutaneous Coronary Intervention

(2016) Kashish Goel et al.   Journal of the American Heart Association

Serum creatinine level, a surrogate of muscle mass, predicts mortality in critically ill patients

(2016) Charat Thongprayoon et al.   Journal of Thoracic Disease

Understanding cachexia as a cancer metabolism syndrome

(2016) P E Porporato   Oncogenesis

A New Equation to Estimate Muscle Mass from Creatinine and Cystatin C

(2016) Sun-wook Kim et al.   PLoS One

Serum Creatinine Modifies Associations between Body Mass Index and Mortality and Morbidity in Prevalent Hemodialysis Patients

(2016) Yukitoshi Sakao et al.   PLoS One

The role of body composition evaluation by computerized tomography in determining colorectal cancer treatment outcomes: A systematic review

(2015) G. Malietzis et al.   EJSO

Protective overweight in cardiovascular disease: moving from ‘paradox’ to ‘paradigm’

(2015) Wolfram Doehner et al.   EUROPEAN HEART JOURNAL

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

(2015) Antoni Ribas et al.   LANCET ONCOLOGY

Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma

(2015) Michael A. Postow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pembrolizumab versus Ipilimumab in Advanced Melanoma

(2015) Caroline Robert et al.   NEW ENGLAND JOURNAL OF MEDICINE

T-cell exhaustion in the tumor microenvironment

(2015) Y Jiang et al.   Cell Death & Disease

Creatinine and myoglobin are poor predictors of anaerobic threshold in colorectal cancer and health

(2015) Sitaramachandra M. Nyasavajjala et al.   Journal of Cachexia Sarcopenia and Muscle

Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment

(2015) Cathleen Drescher et al.   Journal of Cachexia Sarcopenia and Muscle

Obesity paradox in cancer: new insights provided by body composition

(2014) Maria Cristina Gonzalez et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Lean Tissue Imaging

(2014) Carla M. M. Prado et al.   JOURNAL OF PARENTERAL AND ENTERAL NUTRITION

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

(2014) Caroline Robert et al.   LANCET

Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma

(2014) Alexandra Snyder et al.   NEW ENGLAND JOURNAL OF MEDICINE

An Epidemiologic and Genomic Investigation Into the Obesity Paradox in Renal Cell Carcinoma

(2013) A. Ari Hakimi et al.   JNCI-Journal of the National Cancer Institute

Serum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis patients

(2013) Jongha Park et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C

(2012) Lesley A. Inker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature

(2012) Sapna S. Patel et al.   Journal of Cachexia Sarcopenia and Muscle

Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries

(2011) H. Quan et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Identifying Important Risk Factors for Survival in Patient With Systolic Heart Failure Using Random Survival Forests

(2010) Eileen Hsich et al.  

Muscle in defense

(2010) Adam Lightfoot et al.   CRITICAL CARE MEDICINE

High-Dimensional Variable Selection for Survival Data

(2010) Hemant Ishwaran et al.   JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION

Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer

(2009) B. Guiu et al.   GUT

Obesity and Cardiovascular Disease

(2009) Carl J. Lavie et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Random survival forests

(2008) Hemant Ishwaran et al.   Annals of Applied Statistics

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

(2008) Andrew G Renehan et al.   LANCET